The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk
- PMID: 22183849
- PMCID: PMC3244680
- DOI: 10.1097/OLQ.0b013e318235502b
The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk
Abstract
Background: Use of lubricant products is extremely common during receptive anal intercourse (RAI) yet has not been assessed as a risk for acquisition of sexually transmitted infections (STIs).
Methods: Between 2006 and 2008, a rectal health and behavior study was conducted in Baltimore and Los Angeles as part of the University of California, Los Angeles Microbicide Development Program (NIAID IPCP# #0606414). Participants completed questionnaires, and rectal swabs were tested for Neisseria gonorrhoeae and Chlamydia trachomatis with the Aptima Combo 2 assay, and blood was tested for syphilis (for RPR and TPHA with titer) and HIV. Of those reporting lubricant use and RAI, STI results were available for 380 participants. Univariate and multivariate regressions assessed associations of lubricant use in the past month during RAI with prevalent STIs.
Results: Consistent lubricant use during RAI in the past month was reported by 36% (137/380) of participants. Consistent past month lubricant users had a higher prevalence of STI than inconsistent users (9.5% vs. 2.9%; P = 0.006). In a multivariable logistic regression model, testing positive for STI was associated with consistent use of lubricant during RAI in the past month (adjusted odds ratio: 2.98 95% confidence interval: 1.09, 8.15) after controlling for age, gender, study location, HIV status, and numbers of RAI partners in the past month.
Conclusions: Findings suggest some lubricant products may increase vulnerability to STIs. Because of wide use of lubricants and their potential as carrier vehicles for microbicides, further research is essential to clarify if lubricant use poses a public health risk.
Figures
Similar articles
-
Lubricants and rectal douching: associations with rectal gonorrhea, chlamydia, and/or syphilis infection among men who have sex with men.Int J STD AIDS. 2020 Oct;31(11):1040-1046. doi: 10.1177/0956462420938485. Epub 2020 Aug 4. Int J STD AIDS. 2020. PMID: 32753001 Free PMC article.
-
Lubricant Use and Rectal Chlamydial and Gonococcal Infections Among Men Who Engage in Receptive Anal Intercourse.Sex Transm Dis. 2016 Jul;43(7):423-8. doi: 10.1097/OLQ.0000000000000463. Sex Transm Dis. 2016. PMID: 27322042
-
Prevalence of sexually transmitted infections and associated risk factors among female sex workers in Guinea-Bissau.Sex Transm Infect. 2024 Oct 17;100(7):411-417. doi: 10.1136/sextrans-2023-056015. Sex Transm Infect. 2024. PMID: 39137971 Free PMC article.
-
Sexually Transmitted Infection Prevalence in Women With HIV: Is There a Role for Targeted Screening?Sex Transm Dis. 2018 Nov;45(11):762-769. doi: 10.1097/OLQ.0000000000000852. Sex Transm Dis. 2018. PMID: 29642121 Free PMC article.
-
Risk of Human Immunodeficiency Virus Acquisition Among High-Risk Heterosexuals With Nonviral Sexually Transmitted Infections: A Systematic Review and Meta-Analysis.Sex Transm Dis. 2022 Jun 1;49(6):383-397. doi: 10.1097/OLQ.0000000000001601. Epub 2022 Jan 13. Sex Transm Dis. 2022. PMID: 35034049 Free PMC article.
Cited by
-
Rectal pre-exposure prophylaxis (PrEP).Antiviral Res. 2013 Dec;100 Suppl(0):S17-24. doi: 10.1016/j.antiviral.2013.09.023. Epub 2013 Nov 1. Antiviral Res. 2013. PMID: 24188705 Free PMC article. Review.
-
Designing and developing suppository formulations for anti-HIV drug delivery.Ther Deliv. 2017 Aug;8(9):805-817. doi: 10.4155/tde-2017-0056. Ther Deliv. 2017. PMID: 28825395 Free PMC article. Review.
-
Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.Antimicrob Agents Chemother. 2015 Dec 14;60(3):1393-400. doi: 10.1128/AAC.02201-15. Antimicrob Agents Chemother. 2015. PMID: 26666935 Free PMC article.
-
In Vivo Rectal Mucosal Barrier Function Imaging in a Large-Animal Model by Using Confocal Endomicroscopy: Implications for Injury Assessment and Use in HIV Prevention Studies.Antimicrob Agents Chemother. 2016 Jul 22;60(8):4600-9. doi: 10.1128/AAC.00134-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27185807 Free PMC article.
-
Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.Menopause. 2014 May;21(5):450-8. doi: 10.1097/GME.0b013e3182a4690b. Menopause. 2014. PMID: 24080849 Free PMC article.
References
-
- El-Attar SM, DVE Anal warts, sexually transmitted diseases, and anorectal conditions associated with human immunodeficiency virus. Prim Care. 1999;26:81–100. - PubMed
-
- Strang J, Powis B, Griffiths P, Gossop M. Heterosexual vaginal and anal intercourse amongst London heroin and cocaine users. Int J STD AIDS. 1994;5:133–6. - PubMed
-
- Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res. 2010;85:276–85. - PubMed
-
- Dosekun O, Fox J. An overview of the relative risks of different sexual behaviours on HIV transmission. Curr Opin HIV AIDS. 2010;5:291–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous